Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells

被引：10
|
作者：
Erdei, Zsuzsa [1 ]
Schamberger, Anita [1 ]
Torok, Gyorgy [1 ]
Szebenyi, Kornelia [1 ]
Varady, Gyorgy [1 ]
Orban, Tamas I. [1 ]
Homolya, Laszlo [1 ]
Sarkadi, Balks [1 ,2 ]
Apati, Agota [1 ]
机构：
[1] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary
[2] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary
来源：
PLOS ONE | 2018年 / 13卷 / 04期
关键词：
SUBSTRATE-SPECIFICITY; PROTEIN TRANSPORTER; EXPRESSION PATTERN; DRUG TRANSPORTERS; NULL ALLELES; DIFFERENTIATION; SYSTEM; LOCALIZATION; BCRP/ABCG2; PHENOTYPE;
D O I：
10.1371/journal.pone.0194925
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and protects the stem cells against toxins and stress conditions. We have shown earlier that a GFP-tagged version of ABCG2 is fully functional and may be used to follow the expression, localization and function of this transporter in living cells. In the present work we have overexpressed GFP-ABCG2, driven by a constitutive (CAG) promoter, in HUES9 human embryonic stem cells. Stem cell clones were generated to express the wild-type and a substrate-mutant (R482G) GFP-ABCG2 variant, by using the Sleeping Beauty transposon system. We found that the stable overexpression of these transgenes did not change the pluripotency and growth properties of the stem cells, nor their differentiation capacity to hepatocytes or cardiomyocytes. ABCG2 overexpression provided increased toxin resistance in the stem cells, and protected the derived cardiomyocytes against doxorubicin toxicity. These studies document the potential of a stable ABCG2 expression for engineering toxin-resistant human pluripotent stem cells and selected stem cell derived tissues.
引用
收藏
页数：17
相关论文
共 50 条
  • [21] Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter
    Boglárka Zámbó
    Orsolya Mózner
    Zsuzsa Bartos
    György Török
    György Várady
    Ágnes Telbisz
    László Homolya
    Tamás I. Orbán
    Balázs Sarkadi
    Cellular and Molecular Life Sciences, 2020, 77 : 365 - 378
  • [22] Human multidrug transporter ABCG2, a target for sensitizing drug resistance in cancer chemotherapy
    Xu, Junkang
    Peng, Hui
    Zhang, Han-Ting
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (06) : 689 - 701
  • [23] The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology
    Cervenak, J
    Andrikovics, H
    Özvegy-Laczka, C
    Tordai, A
    Német, K
    Váradi, A
    Sarkadi, B
    CANCER LETTERS, 2006, 234 (01) : 62 - 72
  • [24] Generation of stable reporter cell lines to study the transcriptional and translational regulation of the human ABCG2 multidrug transporter
    Kovacsics, D.
    Tihanyi, B.
    Matula, Z.
    Borsy, A.
    Welker, E.
    Szabo, E.
    Varady, G.
    Sarkadi, B.
    Brozik, A.
    FEBS OPEN BIO, 2018, 8 : 287 - 287
  • [25] Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
    Scott M. Jackson
    Ioannis Manolaridis
    Julia Kowal
    Melanie Zechner
    Nicholas M. I. Taylor
    Manuel Bause
    Stefanie Bauer
    Ruben Bartholomaeus
    Guenther Bernhardt
    Burkhard Koenig
    Armin Buschauer
    Henning Stahlberg
    Karl-Heinz Altmann
    Kaspar P. Locher
    Nature Structural & Molecular Biology, 2018, 25 : 333 - 340
  • [26] Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2
    Abel, Biebele
    Murakami, Megumi
    Tosh, Dilip K. K.
    Yu, Jinha
    Lusvarghi, Sabrina
    Campbell, Ryan G. G.
    Gao, Zhan-Guo
    Jacobson, Kenneth A. A.
    Ambudkar, Suresh V.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
  • [27] Effect of the cholesterol on the ATPase and transport activity of the human multidrug transporter protein, ABCG2
    Telbisz, A.
    Bathori, G.
    Krajcsi, P.
    Pal, A.
    Muller, M.
    Varadi, A.
    Sarkadi, B.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 143 (1-2) : 76 - 77
  • [28] Structural basis of small-molecule inhibition of human multidrug transporter ABCG2
    Jackson, Scott M.
    Manolaridis, Ioannis
    Kowal, Julia
    Zechner, Melanie
    Taylor, Nicholas M. I.
    Bause, Manuel
    Bauer, Stefanie
    Bartholomaeus, Ruben
    Bernhardt, Guenther
    Koenig, Burkhard
    Buschauer, Armin
    Stahlberg, Henning
    Altmann, Karl-Heinz
    Locher, Kaspar P.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2018, 25 (04) : 333 - +
  • [29] Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter
    Zambo, Boglarka
    Mozner, Orsolya
    Bartos, Zsuzsa
    Torok, Gyorgy
    Varady, Gyorgy
    Telbisz, Agnes
    Homolya, Laszlo
    Orban, Tamas I.
    Sarkadi, Balazs
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (02) : 365 - 378
  • [30] Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
    Zhang, Yongchao
    Wu, Zhuo-Xun
    Yang, Yuqi
    Wang, Jing-Quan
    Li, Jun
    Sun, Zoey
    Teng, Qiu-Xu
    Ashby, Charles R., Jr.
    Yang, Dong-Hua
    CANCERS, 2020, 12 (11) : 1 - 24
12345